222 related articles for article (PubMed ID: 15981222)
1. Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Am J Hematol; 2005 Jul; 79(3):243-5. PubMed ID: 15981222
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
[TBL] [Abstract][Full Text] [Related]
3. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls.
Stachurski D; Smith BR; Pozdnyakova O; Andersen M; Xiao Z; Raza A; Woda BA; Wang SA
Leuk Res; 2008 Feb; 32(2):215-24. PubMed ID: 17675229
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
[TBL] [Abstract][Full Text] [Related]
9. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
[TBL] [Abstract][Full Text] [Related]
10. The role of flow cytometric immunophenotyping in myelodysplastic syndromes.
Pagnucco G; Giambanco C; Gervasi F
Ann N Y Acad Sci; 2006 Nov; 1089():383-94. PubMed ID: 17261782
[TBL] [Abstract][Full Text] [Related]
11. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia.
Kussick SJ; Fromm JR; Rossini A; Li Y; Chang A; Norwood TH; Wood BL
Am J Clin Pathol; 2005 Aug; 124(2):170-81. PubMed ID: 16040286
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic flow cytometry for low-grade myelodysplastic syndromes.
Ogata K
Hematol Oncol; 2008 Dec; 26(4):193-8. PubMed ID: 18412289
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic abnormalities strongly reflect genotype in patients with unexplained cytopenias.
Cutler JA; Wells DA; van de Loosdrecht AA; de Baca ME; Kalnoski MH; Zehentner BK; Eidenschink L; Ghirardelli KM; Biggerstaff JS; Loken MR
Cytometry B Clin Cytom; 2011 May; 80(3):150-7. PubMed ID: 21520402
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric diagnosis of myelodysplasia and myeloproliferative disorders.
Wood BL
J Biol Regul Homeost Agents; 2004; 18(2):141-5. PubMed ID: 15471218
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
16. A comparative review of classification systems in myelodysplastic syndromes (MDS).
Bennett JM
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
[TBL] [Abstract][Full Text] [Related]
17. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
[TBL] [Abstract][Full Text] [Related]
18. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
Kao JM; McMillan A; Greenberg PL
Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data.
Kern W; Haferlach C; Schnittger S; Haferlach T
Cancer; 2010 Oct; 116(19):4549-63. PubMed ID: 20572043
[TBL] [Abstract][Full Text] [Related]
20. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
